David Baker

David Baker currently serves as the Chairman of the Board and Board Director at Devonian Health Group Inc., alongside roles as Board Director at GRI Bio, Inc. and Board Director at Benchworks. Baker is also a member of Robin Hood Ventures, focusing on early-stage investments. Previously, Baker was the President & CEO of Vallon Pharmaceuticals, overseeing its public offering and merger with GRI Bio. Additional experience includes leading Alcobra as Interim CEO and Chief Commercial Officer, holding various executive roles at Shire Pharmaceuticals focused on ADHD and behavioral health, and serving as Senior Director of Marketing at Merck. Baker's educational background includes an MBA in Marketing and a BA in Economics, both from Duke University.